Table 2.
Modulation of AMR by microbial volatile compounds (MVCs).
MVCs | Origin Microorganism | Target Microorganism | Antimicrobial Resistance | Mechanism | References |
---|---|---|---|---|---|
Trimethylamine | E. coli | E. coli, P. aeruginosa, S. aureus, and B. subtilis | Tetracycline | Increasing the transmembrane pH and lowering the transport of tetracycline inside the cell | [39] |
Ammonia (NH3) | E. coli | E. coli | Tetracycline | Promoting intracellular accumulation of polyamines by modifying membrane permeability | [40] |
Indole | E. coli | Pseudomonas putida | ampicillin | Inducing the Pseudomonas TtgGHI antibiotic efflux pump | [41] |
2,3-Butanedione and glyoxylic acid | B. subtilis | E. coli | Ampicillin and tetracycline | The induction of the expression of hipA and hipB, TA system related genes, resulting in bacterial persistence | [42] |
2-Aminoacetophenone | P. aeruginosa | Acinetobacter baumanii | Meropenem and tetracycline | Stimulating persisters formation | [43] |
Hydrogen sulfide (H2S) | Bacillus anthracis, P. aeruginosa, S. aureus, and E. coli | B. anthracis, P. aeruginosa, S. aureus, and E. coli | A range of different antibiotics targeting DNA, RNA, cell wall, or protein biosynthesis | Mitigation of oxidative stress imposed by antibiotics | [44] |
Dimethyl trisulfide, 1-methylthio-3-pentanone and o-aminoacetophenone | Burkholderia ambifaria | E. coli | Aminoglycosides, such as gentamicin and kanamycin | Unknown | [45] |
Nitric oxide (NO) | Many Gram-positive bacteria, such as B.subtilis and S. aureus | NO producing and non-producing microorganisms | A broad spectrum of antibiotics such as cefuroxime | Chemical modification of toxic compounds and the alleviation of the oxidative stress | [46] |